🔗 Share this article

Chancellor Reeves has revealed she is planning "targeted steps to tackle household expense challenges" in next month's financial statement.

During an interview with media outlets, she emphasized that curbing price rises is a joint duty of both the administration and the Bank of England.

The United Kingdom's inflation rate is forecast to be the most elevated among the Group of Seven advanced economies this calendar year and the following year.

Potential Utility Cost Interventions

It is understood the government could take action to bring down energy bills, for example by reducing the current 5% rate of VAT applied on energy.

An additional possibility is to cut some of the regulatory levies currently added to bills.

Budgetary Constraints and Analyst Predictions

The administration will obtain the latest draft from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much scope there is for these actions.

The expectation from most economists is that Reeves will have to declare tax rises or spending cuts in order to fulfill her voluntary fiscal targets.

Previously on Thursday, calculations indicated there was a twenty-two billion pound gap for the Treasury chief to address, which is at the lower end of expectations.

"There's a collective job between the Bank of England and the administration to continue tackling some of the drivers of price increases," the Chancellor informed reporters in Washington, at the annual meetings of the IMF and global financial institution.

Revenue Pledges and International Concerns

While a great deal of the focus has been on expected tax rises, the Treasury chief said the latest information from the fiscal watchdog had not altered her commitment to election pledges not to raise tax levels on earnings tax, sales tax or social security contributions.

She blamed an "unpredictable global environment" with rising international and commercial tensions for the fiscal revenue measures, probably to be directed on those "wealthiest."

International Economic Tensions

Referring to concerns about the UK's commercial links with the Asian nation she said: "The UK's security interests invariably take priority."

Recent statement by China to tighten trade restrictions on rare earths and other resources that are essential for high-technology production led American leader Donald Trump to suggest an extra 100% tariff on imports from China, raising the prospect of an full-scale trade war between the two largest economies.

The US Treasury Secretary described China's action "economic coercion" and "a global supply chain control attempt."

Questioned on considering the American proposal to participate in its dispute with the Asian nation, Reeves said she was "deeply worried" by China's measures and encouraged the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "bad for the international commerce and generates further obstacles."

"I believe there are sectors where we must address Chinese policies, but there are also significant prospects to sell into China's economy, including financial services and other areas of the economic system. We've got to get that equilibrium appropriate."

The chancellor also stated she was collaborating with other major economies "regarding our own essential resources strategy, so that we are reduced dependence."

NHS Drug Pricing and Funding

Reeves also acknowledged that the price the National Health Service pays for drugs could go up as a consequence of current negotiations with the Trump administration and its drugs companies, in return for reduced taxes and capital.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either delaying or scrapping projects in the UK, with some blaming the insufficient payments they are getting.

Recently, the government science advisor said the price the health service pays for medicines would have to go up to stop businesses and drug research funding leaving the UK.

The Chancellor told media: "It has been observed due to the pricing regime, that clinical trials, new drugs have not been provided in the UK in the way that they are in other European countries."

"The objective is to make sure that patients receiving care from the NHS are able to receive the top life-saving drugs in the globe. And so we are reviewing all of that, and... aiming to attract more capital into Britain."